Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
dc.contributor.author | Chittacharoen, Apichart | en_US |
dc.contributor.author | Domhardt, Reiner | en_US |
dc.contributor.author | Manonai, Jittima | en_US |
dc.contributor.author | Theppisai, Urusa | en_US |
dc.contributor.author | Golbs, Siegfried | en_US |
dc.date.accessioned | 2009-05-27T18:58:26Z | |
dc.date.available | 2009-05-27T18:58:26Z | |
dc.date.issued | 2004-01-20 | en_US |
dc.description | Chotmaihet Thangphaet. | en_US |
dc.description.abstract | The efficacy of the oral hormone replacement therapy (HRT) preparation estradiol valerate/levonorgestrel (EV/LNG, Klimonorm) in the alleviation of the menopausal complaints of peri- and postmenopausal Thai women was studied in a prospective, open, uncontrolled phase IV clinical trial. Of the 50 peri- or postmenopausal women screened, 39 completed the study. From them 31 were postmenopausal and 8 perimenopausal. The participants received EV/LNG over a period of 6 cycles. The Menopause Rating Scale II (MRS II) was used to assess the effect of EV/LNG on the menopausal symptoms. The changes in the main parameters of the MRS II during the treatment with EV/LNG showed that the general score decreased by 34.9 per cent after 3 months and was kept at the same value after 6 months of treatment. The somato-vegetative complaints decreased by 32.5 per cent after 3 months and by 35 per cent after 6 months. The psychological complaints decreased by 34.1 per cent after 3 months and by 32.9 per cent after 6 months. The urogenital complaints decreased by 29.3 per cent after 3 months, and remained at the same level after 6 months of treatment. In conclusion, the 6-months administration of the oral HRT preparation estradiol valerate/levonorgestrel caused a considerable alleviation of the climacteric symptoms in menopausal women. | en_US |
dc.description.affiliation | Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand. | en_US |
dc.identifier.citation | Chittacharoen A, Domhardt R, Manonai J, Theppisai U, Golbs S. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy. Journal of the Medical Association of Thailand. 2004 Jan; 87(1): 1-7 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/40219 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.mat.or.th/journal/all.php | en_US |
dc.subject.mesh | Climacteric --drug effects | en_US |
dc.subject.mesh | Drug Combinations | en_US |
dc.subject.mesh | Estradiol --analogs & derivatives | en_US |
dc.subject.mesh | Estrogen Replacement Therapy --methods | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Levonorgestrel --pharmacology | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.title | Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Clinical Trial, Phase IV | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1